0.1590
+0.0020
+(1.27%)
At close: January 31 at 4:59:38 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-20,453.0000
-16,624.0000
-2,874.0000
-2,089.0000
-9,905.0000
Investing Cash Flow
--
-73.0000
--
--
--
Financing Cash Flow
22,747.0000
17,060.0000
3,056.0000
2,089.0000
9,905.0000
End Cash Position
3,769.0000
4,231.0000
182.0000
--
--
Capital Expenditure
--
-73.0000
--
--
--
Issuance of Capital Stock
--
12,192.0000
--
--
--
Issuance of Debt
30,545.0000
13,248.0000
3,056.0000
2,589.0000
8,857.0000
Repayment of Debt
-2,906.0000
-4,326.0000
--
-500.0000
--
Free Cash Flow
-20,453.0000
-16,697.0000
-2,874.0000
-2,089.0000
-9,905.0000
12/31/2020 - 5/16/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LYTIX.OL Lytix Biopharma AS
5.60
+1.08%
BINV.ST BioInvent International AB (publ)
28.60
+5.73%
FLUI.ST Fluicell AB (publ)
0.0576
+3.60%
ACE.ST Ascelia Pharma AB (publ)
2.9150
+1.92%
RENB Renovaro Inc.
0.7500
-1.99%
FLUO.ST FluoGuide A/S
50.10
+1.11%
RLYB Rallybio Corporation
0.8599
-1.89%
TYRA Tyra Biosciences, Inc.
14.46
-1.70%
HNSA.ST Hansa Biopharma AB (publ)
34.46
+3.73%
PBLA Panbela Therapeutics, Inc.
0.3500
-2.78%